Categories AlphaGraphs, Cannabis, Earnings

Everything you need to know about Aurora Cannabis’ (ACB) Q4 earnings

Aurora Cannabis, Inc. (NASDAQ: ACB) has reported a wider net loss for the fourth quarter of 2022, mainly due to the impact of non-cash impairment charges. The company’s revenues dropped 8% year-over-year during the quarter.

Aurora Cannabis Q4 2022 earnings infographic

The Canada-based medical marijuana company reported a net loss of C$618.8 million for the fourth quarter, compared to a loss of C$134.0 million last year. Adjusted EBITDA loss was C$12.85 million, compared to a loss of C$21.82 million in the prior-year quarter. Total revenues decreased 8% annually to C$50.22 million.

“We continue to enhance the long-term value of our differentiated global cannabis business by quickly identifying highly profitable growth opportunities, deploying capital in a disciplined manner, and continuing to rationalize our cost structure. We remain the #1 Canadian LP in global medical cannabis revenues and expect this high margin, high growth segment to be a key driver for future profitability,” said Miguel Martin, chief executive officer of Aurora Cannabis.


Read management/analysts’ comments on Aurora’s Q4 results


Shares of Aurora Cannabis traded lower Friday afternoon on the Nasdaq stock market, extending the post-earnings losses. The stock has been languishing in the single-digit territory for quite some time.

Prior Performance

  • Aurora Cannabis Q3 2022 earnings infographic
  • Aurora Cannabis Q2 2022 earnings infographic
  • Aurora Cannabis Q1 2022 earnings infographic

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

Nike (NKE) looks set to beat hurdles and build a brighter future

Nike, Inc. (NYSE: NKE) has long been ruling the sportswear market but the company had its share of problems when headwinds like the pandemic and economic slowdown hit the business

Electronic Arts (EA): A few points to keep in mind if you have an eye on this gaming company

Shares of Electronic Arts Inc. (NASDAQ: EA) stayed green on Friday. The stock has dropped 7% over the past three months. The video game industry has been facing challenges as

Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor

Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues. It operates mainly through the business segments of Prescription Medications

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top